SCHEMBL6904745

SCHEMBL6904745

CONC(=O)C(OC)(OC)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 1/20 0.58
KCNN4 O15554 1/20 0.48
TSHR P16473 1/20 0.44
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC10 Q969S8 1/20 0.43
HDAC11 Q96DB2 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
HDAC9 Q9UKV0 1/20 0.43
HDAC5 Q9UQL6 1/20 0.43
KMT2A Q03164 3/20 0.41
MAPT P10636 2/20 0.41
GAA P10253 1/20 0.39
CYP1A2 P05177 2/20 0.38
CYP2D6 P10635 1/20 0.38
SRC P12931 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6497297 0.81 CES1 (0.58) CES1KCNN4TSHRHDAC3HDAC4
SCHEMBL28615437 0.81 KCNN4 (0.62) CES1KCNN4TSHRHDAC3HDAC4
SCHEMBL28627442 0.79 MAPT (0.57) CES1KCNN4TSHRHDAC3HDAC4
SCHEMBL4447296 0.79 HDAC3 (0.63) CES1KCNN4TSHRHDAC3HDAC4
SCHEMBL2028141 0.79 CES1 (0.54) CES1KCNN4TSHRHDAC3HDAC4
SCHEMBL1454439 0.79 CES1 (0.63) CES1KCNN4TSHRHDAC3HDAC4
SCHEMBL5580542 0.79 CES1 (0.69) CES1KCNN4TSHRHDAC3HDAC4
SCHEMBL1585516 0.78 CES1 (0.68) CES1KCNN4TSHRHDAC3HDAC4
SCHEMBL2586906 0.76 CES1 (0.66) CES1KCNN4TSHRHDAC3HDAC4
SCHEMBL6964069 0.76 CES1 (0.66) CES1KCNN4TSHRHDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115038451-A Multimodal compositions and methods of treatment 阿奎斯蒂弗医疗股份有限公司 2022-09-09 CN disclosed
CN-115003279-A Prodrug compositions and methods of treatment 阿奎斯蒂弗医疗股份有限公司 2022-09-02 CN disclosed
CN-114805139-A Prodrugs of ketamine, compositions and uses thereof 凯瑞康宁生物工程(武汉)有限公司 2022-07-29 CN disclosed
CN-108299437-B Octahydropyrrolo [3,4-c ] pyrrole derivatives and uses thereof 广东东阳光药业有限公司 2022-07-08 CN disclosed
CN-109988170-B Octahydropyrrolo [3,4-c ] pyrrole derivatives and uses thereof 广东东阳光药业有限公司 2022-04-26 CN disclosed
CN-109153649-B Allosteric modulators of nicotinic acetylcholine receptors 默沙东公司 2022-04-19 CN disclosed
CN-111836798-B Prodrugs of ketamine, compositions and uses thereof 凯瑞康宁生物工程(武汉)有限公司 2022-04-15 CN disclosed
CN-109988169-B Octahydropyrrolo [3,4-c ] pyrrole derivatives and uses thereof 广东东阳光药业有限公司 2022-02-01 CN disclosed
CN-109956945-B Octahydropyrrolo [3,4-c ] pyrrole derivatives and uses thereof 广东东阳光药业有限公司 2022-01-11 CN disclosed
CN-107759620-B Octahydropyrrolo [3,4-c ] pyrrole derivatives, methods of use, and uses thereof 广东东阳光药业有限公司 2021-11-12 CN disclosed
CN-112119076-A Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors 默沙东公司 2020-12-22 CN disclosed
CN-111836798-A Prodrugs of ketamine, compositions and uses thereof 凯瑞康宁生物工程(武汉)有限公司 2020-10-27 CN disclosed
CN-111433212-A Positive allosteric modulators of muscarinic acetylcholine receptor M4 范德比尔特大学 2020-07-17 CN disclosed
CN-111406058-A Positive allosteric modulators of muscarinic acetylcholine receptor M4 范德比尔特大学 2020-07-10 CN disclosed
CN-111107846-A Heteroaryl allosteric modulators of nicotinic acetylcholine receptors 默沙东公司 2020-05-05 CN disclosed
CN-106986859-B Indole derivatives and uses thereof 广东东阳光药业有限公司 2020-02-11 CN disclosed
US-6743794-B2 MULTIDRUG RESISTANCE PROTEIN; CANCER; 3-(9-CHLORO-3-METHYL-4-OXO-5H-ISOXAZOLO(4,3-C)QUINOLIN-5-YL)) CYCLOHEXYL)-2-PIPERIDYLACETAMIDE ELI LILLY AND COMPANY 2004-06-01 US disclosed